FHLC holdings
Fidelity MSCI Health Care Index ETF
Positions
337 stored of 337 reported, largest first by weight
| # | Holding | ISIN | CUSIP | Weight | Value (USD) | Type | Issuer type | Country | Currency |
|---|---|---|---|---|---|---|---|---|---|
| 101 | Madrigal Pharmaceuticals Inc | US5588681057 | 558868105 | 0.101% | $3.3M | Equity (common) | Corporate | United States | USD |
| 102 | Chemed Corp | US16359R1032 | 16359R103 | 0.101% | $3.3M | Equity (common) | Corporate | United States | USD |
| 103 | Bruker Corp | US1167941087 | 116794108 | 0.097% | $3.2M | Equity (common) | Corporate | United States | USD |
| 104 | Vaxcyte Inc | US92243G1085 | 92243G108 | 0.096% | $3.1M | Equity (common) | Corporate | United States | USD |
| 105 | Lantheus Holdings Inc | US5165441032 | 516544103 | 0.094% | $3.1M | Equity (common) | Corporate | United States | USD |
| 106 | Teleflex Inc | US8793691069 | 879369106 | 0.088% | $2.9M | Equity (common) | Corporate | United States | USD |
| 107 | Bio-Rad Laboratories Inc | US0905722072 | 090572207 | 0.085% | $2.8M | Equity (common) | Corporate | United States | USD |
| 108 | Ligand Pharmaceuticals Inc | US53220K5048 | 53220K504 | 0.081% | $2.6M | Equity (common) | Corporate | United States | USD |
| 109 | Spyre Therapeutics Inc | US00773J2024 | 00773J202 | 0.080% | $2.6M | Equity (common) | Corporate | United States | USD |
| 110 | Hims & Hers Health Inc | US4330001060 | 433000106 | 0.079% | $2.6M | Equity (common) | Corporate | United States | USD |
| 111 | Rhythm Pharmaceuticals Inc | US76243J1051 | 76243J105 | 0.078% | $2.6M | Equity (common) | Corporate | United States | USD |
| 112 | Liquidia Corp | US53635D2027 | 53635D202 | 0.078% | $2.6M | Equity (common) | Corporate | United States | USD |
| 113 | Twist Bioscience Corp | US90184D1000 | 90184D100 | 0.075% | $2.5M | Equity (common) | Corporate | United States | USD |
| 114 | Apogee Therapeutics Inc | US03770N1019 | 03770N101 | 0.074% | $2.4M | Equity (common) | Corporate | United States | USD |
| 115 | Xenon Pharmaceuticals Inc | CA98420N1050 | 98420N105 | 0.073% | $2.4M | Equity (common) | Corporate | Canada | USD |
| 116 | Merit Medical Systems Inc | US5898891040 | 589889104 | 0.073% | $2.4M | Equity (common) | Corporate | United States | USD |
| 117 | 10X Genomics Inc | US88025U1097 | 88025U109 | 0.072% | $2.4M | Equity (common) | Corporate | United States | USD |
| 118 | Sotera Health Co | US83601L1026 | 83601L102 | 0.072% | $2.4M | Equity (common) | Corporate | United States | USD |
| 119 | PTC Therapeutics Inc | US69366J2006 | 69366J200 | 0.069% | $2.3M | Equity (common) | Corporate | United States | USD |
| 120 | Definium Therapeutics Inc | CA24477V1058 | 24477V105 | 0.069% | $2.3M | Equity (common) | Corporate | Canada | USD |
| 121 | Cogent Biosciences Inc | US19240Q2012 | 19240Q201 | 0.069% | $2.3M | Equity (common) | Corporate | United States | USD |
| 122 | Kymera Therapeutics Inc | US5015751044 | 501575104 | 0.067% | $2.2M | Equity (common) | Corporate | United States | USD |
| 123 | Travere Therapeutics Inc | US89422G1076 | 89422G107 | 0.067% | $2.2M | Equity (common) | Corporate | United States | USD |
| 124 | Tempus AI Inc | US88023B1035 | 88023B103 | 0.066% | $2.2M | Equity (common) | Corporate | United States | USD |
| 125 | Envista Holdings Corp | US29415F1049 | 29415F104 | 0.065% | $2.1M | Equity (common) | Corporate | United States | USD |
| 126 | Mirum Pharmaceuticals Inc | US6047491013 | 604749101 | 0.065% | $2.1M | Equity (common) | Corporate | United States | USD |
| 127 | LivaNova PLC | GB00BYMT0J19 | Not reported | 0.063% | $2.1M | Equity (common) | Corporate | United Kingdom | USD |
| 128 | RadNet Inc | US7504911022 | 750491102 | 0.061% | $2.0M | Equity (common) | Corporate | United States | USD |
| 129 | Integer Holdings Corp | US45826H1095 | 45826H109 | 0.060% | $2.0M | Equity (common) | Corporate | United States | USD |
| 130 | Indivior Pharmaceuticals Inc | US45579U1097 | 45579U109 | 0.060% | $2.0M | Equity (common) | Corporate | United States | USD |
| 131 | CRISPR Therapeutics AG | CH0334081137 | Not reported | 0.058% | $1.9M | Equity (common) | Corporate | Switzerland | USD |
| 132 | ICU Medical Inc | US44930G1076 | 44930G107 | 0.058% | $1.9M | Equity (common) | Corporate | United States | USD |
| 133 | Haemonetics Corp | US4050241003 | 405024100 | 0.057% | $1.9M | Equity (common) | Corporate | United States | USD |
| 134 | Dianthus Therapeutics Inc | US2528281080 | 252828108 | 0.057% | $1.9M | Equity (common) | Corporate | United States | USD |
| 135 | IRhythm Holdings Inc | US4500561067 | 450056106 | 0.055% | $1.8M | Equity (common) | Corporate | United States | USD |
| 136 | Veracyte Inc | US92337F1075 | 92337F107 | 0.053% | $1.8M | Equity (common) | Corporate | United States | USD |
| 137 | Concentra Group Holdings Parent Inc | US20603L1026 | 20603L102 | 0.053% | $1.7M | Equity (common) | Corporate | United States | USD |
| 138 | Option Care Health Inc | US68404L2016 | 68404L201 | 0.053% | $1.7M | Equity (common) | Corporate | United States | USD |
| 139 | CG oncology Inc | US1569441009 | 156944100 | 0.052% | $1.7M | Equity (common) | Corporate | United States | USD |
| 140 | Organon & Co | US68622V1061 | 68622V106 | 0.051% | $1.7M | Equity (common) | Corporate | United States | USD |
| 141 | Scholar Rock Holding Corp | US80706P1030 | 80706P103 | 0.051% | $1.7M | Equity (common) | Corporate | United States | USD |
| 142 | Viking Therapeutics Inc | US92686J1060 | 92686J106 | 0.050% | $1.7M | Equity (common) | Corporate | United States | USD |
| 143 | Dyne Therapeutics Inc | US26818M1080 | 26818M108 | 0.050% | $1.7M | Equity (common) | Corporate | United States | USD |
| 144 | Erasca Inc | US29479A1088 | 29479A108 | 0.047% | $1.6M | Equity (common) | Corporate | United States | USD |
| 145 | Brookdale Senior Living Inc | US1124631045 | 112463104 | 0.045% | $1.5M | Equity (common) | Corporate | United States | USD |
| 146 | Denali Therapeutics Inc | US24823R1059 | 24823R105 | 0.045% | $1.5M | Equity (common) | Corporate | United States | USD |
| 147 | Oruka Therapeutics Inc | US6876041087 | 687604108 | 0.044% | $1.4M | Equity (common) | Corporate | United States | USD |
| 148 | Arcutis Biotherapeutics Inc | US03969K1088 | 03969K108 | 0.044% | $1.4M | Equity (common) | Corporate | United States | USD |
| 149 | ACADIA Pharmaceuticals Inc | US0042251084 | 004225108 | 0.043% | $1.4M | Equity (common) | Corporate | United States | USD |
| 150 | Amneal Pharmaceuticals Inc | US03168L1052 | 03168L105 | 0.042% | $1.4M | Equity (common) | Corporate | United States | USD |
| 151 | Hinge Health Inc | US4333131039 | 433313103 | 0.041% | $1.4M | Equity (common) | Corporate | United States | USD |
| 152 | Ideaya Biosciences Inc | US45166A1025 | 45166A102 | 0.041% | $1.3M | Equity (common) | Corporate | United States | USD |
| 153 | National HealthCare Corp | US6359061008 | 635906100 | 0.041% | $1.3M | Equity (common) | Corporate | United States | USD |
| 154 | Kiniksa Pharmaceuticals International Plc | GB00BRXB0C07 | Not reported | 0.040% | $1.3M | Equity (common) | Corporate | United Kingdom | USD |
| 155 | DENTSPLY SIRONA Inc | US24906P1093 | 24906P109 | 0.038% | $1.3M | Equity (common) | Corporate | United States | USD |
| 156 | Adaptive Biotechnologies Corp | US00650F1093 | 00650F109 | 0.038% | $1.3M | Equity (common) | Corporate | United States | USD |
| 157 | GRAIL Inc | US3847471014 | 384747101 | 0.038% | $1.2M | Equity (common) | Corporate | United States | USD |
| 158 | Enliven Therapeutics Inc | US29337E1029 | 29337E102 | 0.037% | $1.2M | Equity (common) | Corporate | United States | USD |
| 159 | ImmunityBio Inc | US45256X1037 | 45256X103 | 0.037% | $1.2M | Equity (common) | Corporate | United States | USD |
| 160 | Immunovant Inc | US45258J1025 | 45258J102 | 0.037% | $1.2M | Equity (common) | Corporate | United States | USD |
| 161 | Celldex Therapeutics Inc | US15117B2025 | 15117B202 | 0.037% | $1.2M | Equity (common) | Corporate | United States | USD |
| 162 | Tango Therapeutics Inc | US87583X1090 | 87583X109 | 0.037% | $1.2M | Equity (common) | Corporate | United States | USD |
| 163 | Doximity Inc | US26622P1075 | 26622P107 | 0.036% | $1.2M | Equity (common) | Corporate | United States | USD |
| 164 | TransMedics Group Inc | US89377M1099 | 89377M109 | 0.036% | $1.2M | Equity (common) | Corporate | United States | USD |
| 165 | Neogen Corp | US6404911066 | 640491106 | 0.036% | $1.2M | Equity (common) | Corporate | United States | USD |
| 166 | Alignment Healthcare Inc | US01625V1044 | 01625V104 | 0.036% | $1.2M | Equity (common) | Corporate | United States | USD |
| 167 | Arcus Biosciences Inc | US03969F1093 | 03969F109 | 0.036% | $1.2M | Equity (common) | Corporate | United States | USD |
| 168 | Waystar Holding Corp | US9467841055 | 946784105 | 0.035% | $1.2M | Equity (common) | Corporate | United States | USD |
| 169 | Supernus Pharmaceuticals Inc | US8684591089 | 868459108 | 0.035% | $1.2M | Equity (common) | Corporate | United States | USD |
| 170 | Prestige Consumer Healthcare Inc | US74112D1019 | 74112D101 | 0.035% | $1.1M | Equity (common) | Corporate | United States | USD |
| 171 | Vericel Corp | US92346J1088 | 92346J108 | 0.034% | $1.1M | Equity (common) | Corporate | United States | USD |
| 172 | Acadia Healthcare Co Inc | US00404A1097 | 00404A109 | 0.033% | $1.1M | Equity (common) | Corporate | United States | USD |
| 173 | Privia Health Group Inc | US74276R1023 | 74276R102 | 0.033% | $1.1M | Equity (common) | Corporate | United States | USD |
| 174 | Beam Therapeutics Inc | US07373V1052 | 07373V105 | 0.033% | $1.1M | Equity (common) | Corporate | United States | USD |
| 175 | Progyny Inc | US74340E1038 | 74340E103 | 0.033% | $1.1M | Equity (common) | Corporate | United States | USD |
| 176 | Relay Therapeutics Inc | US75943R1023 | 75943R102 | 0.032% | $1.1M | Equity (common) | Corporate | United States | USD |
| 177 | Pediatrix Medical Group Inc | US58502B1061 | 58502B106 | 0.032% | $1.0M | Equity (common) | Corporate | United States | USD |
| 178 | Nektar Therapeutics | US6402683063 | 640268306 | 0.031% | $1.0M | Equity (common) | Corporate | United States | USD |
| 179 | Addus HomeCare Corp | US0067391062 | 006739106 | 0.031% | $1.0M | Equity (common) | Corporate | United States | USD |
| 180 | Immunome Inc | US45257U1088 | 45257U108 | 0.030% | $1.0M | Equity (common) | Corporate | United States | USD |
| 181 | Axogen Inc | US05463X1063 | 05463X106 | 0.030% | $989K | Equity (common) | Corporate | United States | USD |
| 182 | Ultragenyx Pharmaceutical Inc | US90400D1081 | 90400D108 | 0.030% | $988K | Equity (common) | Corporate | United States | USD |
| 183 | LeMaitre Vascular Inc | US5255582018 | 525558201 | 0.030% | $987K | Equity (common) | Corporate | United States | USD |
| 184 | uniQure NV | NL0010696654 | Not reported | 0.030% | $972K | Equity (common) | Corporate | Netherlands | USD |
| 185 | NeoGenomics Inc | US64049M2098 | 64049M209 | 0.029% | $953K | Equity (common) | Corporate | United States | USD |
| 186 | Disc Medicine Inc | US2546041011 | 254604101 | 0.028% | $920K | Equity (common) | Corporate | United States | USD |
| 187 | Alumis Inc | US0223071020 | 022307102 | 0.028% | $909K | Equity (common) | Corporate | United States | USD |
| 188 | CareDx Inc | US14167L1035 | 14167L103 | 0.027% | $904K | Equity (common) | Corporate | United States | USD |
| 189 | LifeStance Health Group Inc | US53228F1012 | 53228F101 | 0.027% | $896K | Equity (common) | Corporate | United States | USD |
| 190 | BioCryst Pharmaceuticals Inc | US09058V1035 | 09058V103 | 0.027% | $889K | Equity (common) | Corporate | United States | USD |
| 191 | ADMA Biologics Inc | US0008991046 | 000899104 | 0.027% | $887K | Equity (common) | Corporate | United States | USD |
| 192 | Edgewise Therapeutics Inc | US28036F1057 | 28036F105 | 0.027% | $881K | Equity (common) | Corporate | United States | USD |
| 193 | UFP Technologies Inc | US9026731029 | 902673102 | 0.027% | $878K | Equity (common) | Corporate | United States | USD |
| 194 | PACS Group Inc | US69380Q1076 | 69380Q107 | 0.026% | $859K | Equity (common) | Corporate | United States | USD |
| 195 | AtriCure Inc | US04963C2098 | 04963C209 | 0.026% | $856K | Equity (common) | Corporate | United States | USD |
| 196 | SELLAS Life Sciences Group Inc | US81642T2096 | 81642T209 | 0.026% | $854K | Equity (common) | Corporate | United States | USD |
| 197 | Tarsus Pharmaceuticals Inc | US87650L1035 | 87650L103 | 0.025% | $836K | Equity (common) | Corporate | United States | USD |
| 198 | Trevi Therapeutics Inc | US89532M1018 | 89532M101 | 0.025% | $831K | Equity (common) | Corporate | United States | USD |
| 199 | Fortrea Holdings Inc | US34965K1079 | 34965K107 | 0.025% | $830K | Equity (common) | Corporate | United States | USD |
| 200 | Clover Health Investments Corp | US18914F1030 | 18914F103 | 0.025% | $807K | Equity (common) | Corporate | United States | USD |